Table 3. Annual incidence of systemic amyloidosis in different regions.

Authors and year	Country	Period	Annual incidence
Posadas-Martínez et al, current study	Argentina	2011–2022	ATTRwt amyloidosis (over 60 years): 66/1 000 000 person–yearsAL amyloidosis: 16/1 000 000 person–yearsAA amyloidosis: 4/1 000 000 person–years
Kyle et al, 1992	USA	1950–1989	AL amyloidosis: 6.0 to 10.5/1 000 000 person–years6
Laires et al, 202315	USA		AL amyloidosis: 16.7/1 000 000 person–years15
Cappelli et al, 202316	Italy	2006–2022	ATTRwt amyloidosis: 14.4 to 26.7/1 000 000 person–years.16 ATTRv amyloidosis: 0.8 to 2.7/1 000 000 person–years.
Mellqvist et al, 202317	Swedish	2011–2019	AL amyloidosis: 10.5 to 15.1/1 000 000 person-years17
Dammy et al, 202318	France	2011–2019	ATTR-CA: 0.6 to 3.6/100 000 person-years18
Hemminki et al, 20128	Swedish	2001–2008	All types: 8.29/1 000 000 person-years. Secondary systemic amyloidosis: 1.18/1 000 000 person-years8
Pinney et al, 20137	UK	2000–2008	All types: 0.2 to 0.4/100 000 person-years AL amyloidosis: 0.3 to 0.3/100 000 person-years7
Laires et al, 202419	USA	2018–2022	ATTR-CA: 6/1 000 000 person-years19
Gilstrap et al, 201920	USA	2000–2012	ATTR-CA: 1.8 to 5.5/1 000 000 person-years20
Guha et al, 202421	UK	2004–2021	ATTR-CA: 0.7–1.96/100 000 person-years21
Choi et al, 202422	Korea	2008–2020	ATTR-CA: 0.09–0.22/100 000 person-years22
Quock et al, 201814	USA	2007–2015	Amyloidosis AL: 9.7 to 14.0/1 000 000 person-years14 22
Brink et al	Netherlands	2017–2018	Amyloidosis AL: 6.0/1 000 000 person-years